http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-200633692-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb66d9373d09efad73c142762f6dfb00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138
filingDate 2005-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5953e27a874ce0cb47f5bacadb8692ce
publicationDate 2006-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-200633692-A
titleOfInvention Use of alpha-adrenergic blockers for the treatment of dysmenorrhea
abstract A method of treating primary dysmenorrhea which comprises administering to a human female suffering from the same a therapeutically effective amount of alpha-adrenergic blocker. Exemplary alpha-adrenergic blockers are phenoxybenzamine, alfuzosin, doxazosin, terazosin, prazosin, and tamsulosin, or a pharmaceutically acceptable salt or ester thereof. Tamsulosin HCl is preferred.
priorityDate 2004-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552794
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4893
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4768
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535626
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504078
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409343598
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493489
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129211
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5401

Total number of triples: 28.